Supriya Lifescience Ltd

{"amount":1}

{"description":"Supriya Lifescience rose 15% after strong Q4 results, with management citing higher capacity utilisation, global expansion and contributions from new products.","url":"https://www.business-standard.com/markets/news/supriya-lifescience-up-15-on-healthy-q4-results-should-you-buy-or-hold-126052900425_1.html","sentiment":"Positive","domain":"Business Standard"}

{"description":"Supriya Lifescience's standalone net profit jumped 47.34% to Rs 74.23 crore in the March 2026 quarter, while sales rose 50.20% to Rs 276.53 crore.","url":"https://www.business-standard.com/markets/capital-market-news/supriya-lifescience-standalone-net-profit-rises-47-34-in-the-march-2026-quarter-126052800319_1.html","sentiment":"Positive","domain":"Business Standard"}

{"description":"Supriya Lifescience, a Smallcap in the Pharmaceuticals sector, has a current share price of ₹673 on the BSE. The stock has seen fluctuations today, indicating market volatility.","url":"https://www.financialexpress.com/market/supriya-lifescience-ltd-share-price/","sentiment":"Neutral","domain":"The Financial Express"}